Growth Metrics

Jazz Pharmaceuticals (JAZZ) Current Taxes (2016 - 2025)

Jazz Pharmaceuticals has reported Current Taxes over the past 14 years, most recently at $56.4 million for Q4 2025.

  • Quarterly results put Current Taxes at $56.4 million for Q4 2025, up 200.62% from a year ago — trailing twelve months through Dec 2025 was $56.4 million (up 200.62% YoY), and the annual figure for FY2025 was $56.4 million, up 200.62%.
  • Current Taxes for Q4 2025 was $56.4 million at Jazz Pharmaceuticals, down from $91.1 million in the prior quarter.
  • Over the last five years, Current Taxes for JAZZ hit a ceiling of $91.1 million in Q3 2025 and a floor of $3.6 million in Q2 2021.
  • Median Current Taxes over the past 5 years was $37.6 million (2023), compared with a mean of $40.6 million.
  • Biggest five-year swings in Current Taxes: crashed 93.49% in 2021 and later surged 1065.1% in 2023.
  • Jazz Pharmaceuticals' Current Taxes stood at $9.6 million in 2021, then decreased by 19.68% to $7.7 million in 2022, then surged by 354.5% to $35.1 million in 2023, then crashed by 46.52% to $18.8 million in 2024, then skyrocketed by 200.62% to $56.4 million in 2025.
  • The last three reported values for Current Taxes were $56.4 million (Q4 2025), $91.1 million (Q3 2025), and $78.6 million (Q2 2025) per Business Quant data.